Direct enzymatic assay for %HbA1c in human whole blood samples

Clinical Biochemistry

Volumn 41, Issue 7-8, 2008, Pages 576-583

  Liu, Limin ^a   Hood, Stefanie ^a   Wang, Yuping ^a   Bezverkov, Robert ^a   Dou, Chao ^a   Datta, Abhijit ^a   Yuan, Chong ^a  

^a Diazyme Laboratories   (United States)

Author keywords

Diabetes; Enzymatic HbA1c; Glycated hemoglobin; HbA1c; Human whole blood

Indexed keywords

CHEMICAL COMPOUND; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HEMOGLOBIN VARIANT;

ACCURACY; ARTICLE; AUTOANALYZER; BLOOD SAMPLING; CONTROLLED STUDY; ENZYMATIC ASSAY; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BLOOD CHEMICAL ANALYSIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOENZYME TECHNIQUES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 41849140422     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.01.013     Document Type: Article

References (27)

1. American Diabetes Association. Clinical practice recommendation: standards of medical care for patients with diabetes mellitus. Diabetes Care 22 (1999) S32-S41
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
4. Rohlfing C.L., Wiedmeyer H.M., Little R.R., England J.D., Tennill A., and Goldstein D.E. Defining the relationship between plasma glucose and HbA1c. Diabetes Care 25 (2002) 275-278
5. Kobold U., Jeppsspn J.O., Dulffer T., Finke A., Hoelzel W., and Miedema K. Candidate reference methods for hemoglobin A1c based on peptide mapping. Clin Chem 43 (1997) 1944-1951
6. Jeppsson J.O., Kobold U., Barr J., Finke A., Hoelzel W., Hoshino T., et al. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40 (2002) 78-89
7. In: Kahn R. (Ed). Consensus Committee of IFCC, ADA, EADS, IDF. Consensus statement on the Worldwide Standardization of Hemoglobin A1c Measurement. Diabetes Care vol. 30 (2007) 2399-2400
8. Sacks D.B. Global harmonization of hemoglobin A1c. Clin Chem 51 (2005) 681-683
9. Bry L., Chen P.C., and Sacks D.B. Effects of hemoglobin variants and chemically modified derivatives on assays for glycated hemoglobin. Clin Chem 47 (2001) 153-163
10. Sakurabayashi I., Watano T., Yonehara S., Ishimaru K., Hirai K., Komori T., et al. New enzymatic assay for glycohemoglobin. Clin Chem 49 (2003) 269-274
11. Schnedl W.J., Lahousen T., Lang T., Lipp RW., Yonehara S., Fukunaga S., et al. Determination of glycated hemoglobin in clinically silent hemoglobin variants. Diabetes Metab Res Rev 20 (2004) 460-465
12. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., and Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48 (2002) 436-472
13. Roche Diagnostics Tina-quant Hemoglobin A1C II-Application Instruction Guide 11867539001 Version 10. Revised: March, 2006. Roche Diagnostics, Indianapolis, IN.
14. Roberts W.L., Safar-Pour S., De B.K., Rohlfing C.L., Weykamp C.W., and Little R.R. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem 51 (2005) 776-778
15. NCCLS. Interference testing in Clinical Chemistry. Approved Guideline. NCCLS document EP7-A (2002), NCCLS, Wayne, PA
16. NCCLS. Method comparison and bias estimation using patient samples; Approved Guideline-Second Edition. NCCLS document EP9-A2 (2002), NCCLS, Wayne, PA
17. NCCLS. Evaluation of precision performance of quantitative measurement methods; approved guideline-Second Edition. NCCLS document EP5-A2 (2004), NCCLS, Wayne, PA
18. Armbruster D.A., Tillman M.D., and Hubbs L.M. Limit of detection (LOD)/limit of quantitation (LOQ): comparison of the empirical and the statistical methods exemplified with GC-MS assays of abused drugs. Clin Chem 40 (1994) 1233-1238
19. Tosoh G7 HPLC Application Instruction Guide Version 1.1. Revised: September, 2002. Tosoh, South San Francisco, CA.
20. Armbuster D.A. Fructosamine: structure, analysis and clinical usefulness. Clin Chem 33 12 (1987) 2153-2163
21. Kouzuma T., Usami T., Yamakoshi M., Takahashi M., and Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chimi Acta 324 (2002) 61-71
22. Little R.R. Glycated hemoglobin standardization-National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med 41 (2003) 1191-1198
23. NCCLS. Evaluation of linearity of quantitative measurement procedure: a statistical approach; Approved Guideline. NCCLS document EP6-A (2003), NCCLS, Wayne, PA
24. Hirokawa K., Nakamura K., and Kajiyama N. Enzymes used for the determination of HbA1c. FEMS Microbiol Lett 235 (2004) 157-162
25. Akazawa S., Karino T., Yoshida N., Katsuragi T., and Tani Y. Functional analysis of fructosyl-amino acid oxidases of Aspergillus oryzae. Appl Environ Microbiol 70 (2004) 2882-5890
26. 1c analysis: problem solved. Clin Chem 49 (2003) 1245-1247
27. Little R.R., and Rohlfing C.L. The importance of precision for hemoglobin A1c measurement. Diabetes Technol Ther 5 (2003) 976-981